摘要 |
<p>This invention is concerned with compounds of the formula (I) wherein A, B<SUP>1</SUP>, B<SUP>2</SUP>, R<SUP>1</SUP>, R<SUP>2</SUP> and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.</p> |
申请人 |
F. HOFFMANN-LA ROCHE AG;BINGGELI, ALFRED;CHRIST, ANDREAS, DOMINIK;GREEN, LUKE, GIDEON, GRANVILLE;GUBA, WOLFGANG;MAERKI, HANS-PETER;MARTIN, RAINER, EUGEN;MOHR, PETER |
发明人 |
BINGGELI, ALFRED;CHRIST, ANDREAS, DOMINIK;GREEN, LUKE, GIDEON, GRANVILLE;GUBA, WOLFGANG;MAERKI, HANS-PETER;MARTIN, RAINER, EUGEN;MOHR, PETER |